Business Segment Information (Tables)

3 Months Ended

May 04, 2024

Segment Reporting [Abstract]

Schedule of Business Segment Information

Three Months Ended May 4, 2024
(In thousands)	Journeys Group			Schuh Group			Johnston & Murphy Group		Genesco Brands Group			Corporate & Other			Consolidated
Sales	$	259,445		$	92,349		$	79,207	$	28,593		$	—		$	459,594
Intercompany sales		—			—			—		(1,997	)		—			(1,997	)
Net sales to external customers(1)		259,445			92,349			79,207		26,596			—			457,597
Segment operating income (loss)		(18,822	)		(5,896	)		2,355		(986	)		(8,201	)		(31,550	)
Asset impairments and other(2)		—			—			—		—			578			578
Operating income (loss)		(18,822	)		(5,896	)		2,355		(986	)		(8,779	)		(32,128	)
Other components of net periodic benefit cost		—			—			—		—			109			109
Interest expense, net		—			—			—		—			890			890
Earnings (loss) from continuing operations before income taxes	$	(18,822	)	$	(5,896	)	$	2,355	$	(986	)	$	(9,778	)	$	(33,127	)
Total assets (3)	$	653,489		$	209,372		$	153,890	$	54,716		$	235,950		$	1,307,417
Depreciation and amortization		8,612			1,869			1,382		314			1,060			13,237
Capital expenditures		3,491			733			1,715		231			207			6,377

(1) Net sales in North America and in the U.K., which includes the ROI, accounted for 80% and 20%, respectively, of our net sales in the first quarter of Fiscal 2025.

(2) Asset impairments and other includes a $0.3 million charge for asset impairments in Journeys Group and $0.3 million for severance.

(3) Of our $653.7 million of long-lived assets, $90.0 million and $11.9 million relate to long-lived assets in the U.K. and Canada, respectively.

Three Months Ended April 29, 2023
(In thousands)	Journeys Group			Schuh Group			Johnston & Murphy Group			Genesco Brands Group			Corporate & Other			Consolidated
Sales	$	272,190		$	93,105		$	82,630		$	35,864		$	—		$	483,789
Intercompany sales		—			—			(3	)		(454	)		—			(457	)
Net sales to external customers(1)		272,190			93,105			82,627			35,410			—			483,332
Segment operating income (loss)		(18,362	)		(1,790	)		4,806			(32	)		(7,311	)		(22,689	)
Asset impairments and other (2)		—			—			—			—			308			308
Operating income (loss)		(18,362	)		(1,790	)		4,806			(32	)		(7,619	)		(22,997	)
Other components of net periodic benefit cost		—			—			—			—			92			92
Interest expense, net		—			—			—			—			1,651			1,651
Earnings (loss) from continuing operations before income taxes	$	(18,362	)	$	(1,790	)	$	4,806		$	(32	)	$	(9,362	)	$	(24,740	)
Total assets (3)	$	765,064		$	212,579		$	187,247		$	78,313		$	252,109		$	1,495,312
Depreciation and amortization		7,347			1,561			1,120			203			1,055			11,286
Capital expenditures		13,019			2,151			1,205			455			405			17,235

(1) Net sales in North America and in the U.K., which includes the ROI, accounted for 81% and 19%, respectively, of our net sales for the first quarter of Fiscal 2024.

(2) Asset impairments and other includes a $0.3 million charge for asset impairments in Journeys Group.

(3) Of our $717.1 million of long-lived assets, $91.2 million and $15.4 million relate to long-lived assets in the U.K. and Canada, respectively.